IPCALAB.NS
Ipca Laboratories Limited$1,613.60
Jun 11, 2026
Market cap
$409.12B
52w range
—
P / E
—
EPS · FY 2026
$44.98
Volume
—
Revenue · FY 2026
$96.46B
Explain this page
Arphra AIPlain-English read on Ipca Laboratories Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$986.74
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Energy+2.15%
- Utilities+1.63%
- Technology+0.61%
- Consumer Defensive+0.60%
- Real Estate+0.58%
- Basic Materials+0.51%
- Financial Services-0.09%
- Industrials-0.21%
- Communication Services-0.51%
- Consumer Cyclical-0.70%
- Healthcare-1.17%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-1.13%
- Oil & Gas Energy+9.41%
- Computer Hardware+4.55%
- Coal+3.52%
- Broadcasting-3.37%
- Oil & Gas Exploration & Production+3.08%
- Solar+2.99%
- Investment - Banking & Investment Services+2.91%
- Medical - Healthcare Information Services-2.85%
- Oil & Gas Refining & Marketing+2.74%
- Silver+2.61%
- Copper+2.09%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for IPCALAB.NS.
Peers
No peer list available for IPCALAB.NS.
Total assets
$123.7B
Total debt
$8.09B
Cash & equiv
$5.65B
Operating CF
$11.42B
Free cash flow
$4.86B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $96.46B | $23.32B | $11.41B | $44.98 | +11.83% |